CHRISTOPHER, John Andrew,CONGREVE, Miles Stuart,BUCKNELL, Sarah Joanne,DEFLORIAN, Francesca,PICKWORTH, Mark,MASON, Jonathan Stephen
申请号:
SG11201803382X
公开号:
SG11201803382XA
申请日:
2016.10.28
申请国别(地区):
SG
年份:
2018
代理人:
摘要:
wherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.